Serostatus testing and dengue vaccine cost–benefit thresholds

The World Health Organization (WHO) currently recommends pre-screening for past infection prior to administration of the only licensed dengue vaccine, CYD-TDV. Using a threshold modelling analysis, we identify settings where this guidance prohibits positive net-benefits, and are thus unfavourable. G...

Descripción completa

Detalles Bibliográficos
Autores principales: Pearson, Carl A. B., Abbas, Kaja M., Clifford, Samuel, Flasche, Stefan, Hladish, Thomas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society 2019
Materias:
Life Sciences–Mathematics interface
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731500/
https://www.ncbi.nlm.nih.gov/pubmed/31431184
http://dx.doi.org/10.1098/rsif.2019.0234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731500/
https://www.ncbi.nlm.nih.gov/pubmed/31431184
http://dx.doi.org/10.1098/rsif.2019.0234

Ejemplares similares